145 related articles for article (PubMed ID: 4065184)
1. Serum low-density lipoprotein and high-density lipoprotein cholesterol, and liver size in subjects on drugs inducing hepatic microsomal enzymes.
Luoma PV; Sotaniemi EA; Pelkonen RO; Pirttiaho HI
Eur J Clin Pharmacol; 1985; 28(6):615-8. PubMed ID: 4065184
[TBL] [Abstract][Full Text] [Related]
2. Plasma high-density lipoproteins and hepatic microsomal enzyme induction. Relation to histological changes in the liver.
Luoma PV; Sotaniemi EA; Pelkonen RO; Arranto A; Ehnholm C
Eur J Clin Pharmacol; 1982; 23(3):275-82. PubMed ID: 7173298
[TBL] [Abstract][Full Text] [Related]
3. Inverse relationship of serum LDL cholesterol and the LDL/HDL cholesterol ratio to liver microsomal enzyme induction in man.
Luoma PV; Sotaniemi EA; Pelkonen RO
Res Commun Chem Pathol Pharmacol; 1983 Oct; 42(1):173-6. PubMed ID: 6648042
[TBL] [Abstract][Full Text] [Related]
4. Relationship between plasma high-density lipoprotein cholesterol and anticonvulsant levels in epileptics.
Luoma PV; Myllylä VV; Hokkanen E
J Cardiovasc Pharmacol; 1982; 4(6):1024-7. PubMed ID: 6185767
[TBL] [Abstract][Full Text] [Related]
5. Microsomal enzyme induction, lipoproteins and atherosclerosis.
Luoma PV
Pharmacol Toxicol; 1988 May; 62(5):243-9. PubMed ID: 3045791
[TBL] [Abstract][Full Text] [Related]
6. Serum LDL cholesterol, the LDL/HDL cholesterol ratio and liver microsomal enzyme induction evaluated by antipyrine kinetics.
Luoma PV; Sotaniemi EA; Arranto AJ
Scand J Clin Lab Invest; 1983 Dec; 43(8):671-5. PubMed ID: 6665516
[TBL] [Abstract][Full Text] [Related]
7. Serum lipid changes during anticonvulsive treatment serum lipids in epileptic children.
Yilmaz E; Doşan Y; Gürgöze MK; Güngör S
Acta Neurol Belg; 2001 Dec; 101(4):217-20. PubMed ID: 11851028
[TBL] [Abstract][Full Text] [Related]
8. [Serum lipids. lipoproteins, and apolipoproteins in adult epileptics treated with carbamazepine, valproic acid, or phenytoin].
Pita-Calandre E; Rodríguez-López CM; Cano MD; Peña-Bernal M
Rev Neurol; 1998 Nov; 27(159):785-9. PubMed ID: 9859151
[TBL] [Abstract][Full Text] [Related]
9. Liver enzyme induction and serum lipid levels after replacement of carbamazepine with oxcarbazepine.
Isojärvi JI; Pakarinen AJ; Rautio A; Pelkonen O; Myllylä VV
Epilepsia; 1994; 35(6):1217-20. PubMed ID: 7988514
[TBL] [Abstract][Full Text] [Related]
10. Effects of long-term treatment with antiepileptic drugs on serum lipid levels in children with epilepsy.
Eirís JM; Lojo S; Del Río MC; Novo I; Bravo M; Pavón P; Castro-Gago M
Neurology; 1995 Jun; 45(6):1155-7. PubMed ID: 7783881
[TBL] [Abstract][Full Text] [Related]
11. Microsomal enzyme inducers raise plasma high-density lipoprotein cholesterol levels in healthy control subjects but not in patients with primary hypoalphalipoproteinemia.
Franceschini G; Werba JP; D'Acquarica AL; Gianfranceschi G; Michelagnoli S; Sirtori CR
Clin Pharmacol Ther; 1995 Apr; 57(4):434-40. PubMed ID: 7712672
[TBL] [Abstract][Full Text] [Related]
12. Plasma HDL cholesterol and blood glucose in non-insulin-dependent diabetics related to liver lipids and microsomal enzyme activity.
Luoma PV; Savolainen MJ; Sotaniemi EA; Arranto AJ; Pelkonen RO
Acta Med Scand; 1985; 217(5):473-9. PubMed ID: 4025003
[TBL] [Abstract][Full Text] [Related]
13. Effect of phenobarbital upon serum cholesterol lipoprotein fractions of three rodent species.
Romaschin AD; Goldberg DM
Clin Physiol Biochem; 1987; 5(2):77-84. PubMed ID: 3476234
[TBL] [Abstract][Full Text] [Related]
14. Effects of misoprostol on circulating HDL-cholesterol, total cholesterol, triglycerides and their relationship with hepatic microsomal function.
Godinho AF; Silva MA
Pharmacol Toxicol; 1995 Oct; 77(4):255-8. PubMed ID: 8577636
[TBL] [Abstract][Full Text] [Related]
15. Plasma high-density lipoproteins and liver lipids and proteins in man. Relation to hepatic histology and microsomal enzyme induction.
Luoma PV; Savolainen MJ; Sotaniemi EA; Pelkonen RO; Arranto AJ; Ehnholm C
Acta Med Scand; 1983; 214(2):103-9. PubMed ID: 6624542
[TBL] [Abstract][Full Text] [Related]
16. Plasma high-density lipoprotein cholesterol and hepatic cytochrome P-450 concentrations in epileptics undergoing anticonvulsant treatment.
Luoma PV; Sotaniemi EA; Pelkonen RO; Myllylä VV
Scand J Clin Lab Invest; 1980 Apr; 40(2):163-7. PubMed ID: 7256184
[TBL] [Abstract][Full Text] [Related]
17. Comparison of CYP3A4-Inducing Capacity of Enzyme-Inducing Antiepileptic Drugs Using 4β-Hydroxycholesterol as Biomarker.
Hole K; Wollmann BM; Nguyen C; Haslemo T; Molden E
Ther Drug Monit; 2018 Aug; 40(4):463-468. PubMed ID: 29649093
[TBL] [Abstract][Full Text] [Related]
18. Total cholesterol, low density lipoprotein cholesterol, and high density lipoprotein cholesterol and coronary heart disease in Scotland.
Hargreaves AD; Logan RL; Thomson M; Elton RA; Oliver MF; Riemersma RA
BMJ; 1991 Sep; 303(6804):678-81. PubMed ID: 1912914
[TBL] [Abstract][Full Text] [Related]
19. Influence of drugs and chemical upon hepatic enzymes and proteins-I. Structure-activity relationship between various barbiturates and microsomal enzyme induction in rat liver.
Adachi Y; Yamamoto T
Biochem Pharmacol; 1976 Mar; 25(6):663-8. PubMed ID: 6036
[No Abstract] [Full Text] [Related]
20. High density lipoprotein cholesterol low serum level as the only risk factor in male patients with coronary heart disease.
Alessandri C; Basili S; Peverini F; Barsi R; Paradiso M; Coppotelli L; Violi F; Cordova C
Clin Ter; 1992 Aug; 141(8):109-14. PubMed ID: 1395453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]